COVID-19 Response

ActiGraph COVID-19 Update – July 30, 2020

Dear Valued Customers,

Due to the continued surge of COVID-19 cases in our area, most ActiGraph team members will continue to work remotely until at least September 7, 2020. Our departments have adopted procedures to ensure business continuity during this time, while also protecting the health and safety of our team members, clients, partners, and community.

Inventory/Logistics

We will continue to safely and effectively meet logistics and order fulfillment commitments with minimal interruptions. As we ship exclusively with FedEx, please visit https://www.fedex.com/en-us/coronavirus.html to view an updated list of delivery restrictions imposed by FedEx.

All inbound inventory and return shipments are disinfected with Lysol® and alcohol. All logistics team members are required to wear gloves and masks when handling any inventory items (both inbound and outbound).

Quality Assurance

Quality inspections of finished devices will continue to ensure they meet quality standards. Our inspectors wear masks, and the work environment has been modified to allow proper distancing for team member safety.

Quality management processes are fully operational remotely using validated electronic systems, including: document and change control, quality events, regulatory oversight, and vendor management. Customer audits are being conducted remotely until further notice.

Software

We will continue to effectively meet software commitments and timelines without interruption through the adoption of a work from home policy for the software engineering staff. All team members are required to clear any office visits with a supervisor, and keep time spent on premises to a minimum. Any necessary visits to the office require a self screening upon entry, and team members must wear a face mask while on premises. Virtual meetings are strongly encouraged when face-to-face collaboration is required.

Support

Our customer support team is equipped for both office and home-based support calls and emails. We anticipate no impact to our customer support hours.

Sincerely,

Jeremy Wyatt
CEO


ActiGraph COVID-19 Update – July 14, 2020

Dear Valued Customers,

In response to the surge in COVID-19 cases in our local area, ActiGraph employees are working remotely until further notice. Orders and shipping will continue to function on schedule. In addition, our travel restrictions have been extended until further notice.

We appreciate your patience as we take these necessary precautions to protect the health and safety of our employees and our community.

Sincerely,

Jeremy Wyatt
CEO


ActiGraph COVID-19 Update – June 25, 2020

Dear Valued Customers,

In response to the recent surge in COVID-19 cases in our local area, all ActiGraph employees are working remotely until July 13th, 2020. Shipping delays should be expected during this time. In addition, our travel restrictions have been extended through July 31st until further notice.

We appreciate your patience as we take these necessary precautions to protect the health and safety of our employees and our community.

Sincerely,

Jeremy Wyatt
CEO


ActiGraph COVID-19 Update – May 22, 2020

Dear Valued Customers,

ActiGraph continues to be fully operational with many employees still working remotely. Employees servicing hardware and inventory are reporting to the offices in a rotation to maintain social distance. ActiGraph will begin implementing a plan on June 1 to safely reopen our offices for employees according to current Phase 1 guidelines outlined in Florida State’s Recovery Plan. In addition, our travel cancellations will extend through June 30th until further notice.

ActiGraph remains committed to the health and safety of our employees as we continue to deliver vital digital health outcomes to our clients and the patients who depend on them.

Sincerely,

Jeremy Wyatt
President


ActiGraph COVID-19 Update – March 31, 2020

Dear Valued Customers,

As of March 31, 2020, there are no significant updates to our message below. Most of our team will continue to work remotely through April 30 per current guidelines. Employees servicing hardware and inventory will continue to report to the offices in a rotation until further notice. In addition, our travel cancellations will extend through April 30 until further notice.

Our customers are like family to us. In these unprecedented times, we hope that you and your loved ones are staying safe and healthy. If we can be of any assistance, please don’t hesitate to reach out to us via our support channels.

Sincerely,

Jeremy Wyatt
President


ActiGraph COVID-19 Update – March 24, 2020

Dear Valued Customers,

We realize that you depend on ActiGraph’s products and solutions for your active and upcoming clinical trials and research studies. We also realize that delays on our end could impact your timelines significantly. As we navigate the COVID-19 pandemic together, we are committed to communicating any potential roadblocks that may impact your work.

We want to assure you that ActiGraph is working closely with our clients and supply chain partners so we can continue to deliver the products and services you need during these unprecedented times.

Business Operations

Our operations are up and running with many employees working from home. Our teams are equipped with the technology and tools they need to continue to serve you during our regular business hours. Many of our pharmaceutical clients are hosting virtual meetings, and our account managers have been attending and contributing. We do not anticipate delays in responding to service requests.

Manufacturing

As of Tuesday, March 24, 2020, our hardware manufacturers have no plans to halt or decrease production. Our parts suppliers are flush with stock, and our plastic housing manufacturers have indicated they will be able to keep up with expected demands.

Despite the hardships we are all experiencing during this time, we feel encouraged that we’re on the right path. The ability to capture and deliver remote patient data is in our DNA, and our mission has taken on a new sense of urgency in the face of this global pandemic. We see a promising future in clinical trials and academic studies, and we will continue to press forward to fulfill our mission of helping people live better, longer lives through innovative collaborations with partners like you.

If you have any questions or concerns, please reach out to our Support Team. We’re happy to help in any way that we can.

Sincerely,

Jeremy Wyatt
President


ActiGraph Response to Novel Coronavirus (COVID-19)

In response to the global novel coronavirus (COVID-19) pandemic, ActiGraph is actively monitoring external factors that could impact our ability to fulfill orders and meet our customers’ needs. We have enacted procedures to ensure the safe handling of outgoing materials and minimize disruption to active and upcoming studies. In addition, we have policies, procedures, and tools in place to ensure that our teams are able to work remotely to support business operations should the need arise. We will continue to monitor this evolving situation and update this statement as needed.

Materials Handling

All inbound shipping boxes are sanitized with Lysol® disinfectant upon arrival and again before they are opened. All components and products received are sanitized with alcohol prep pads and handled with sterile latex-free gloves.

Inventory

We are not currently experiencing any inventory supply chain delays. In preparation for any forthcoming delays, we have identified additional materials suppliers and ordered a surplus of inventory items to minimize order fulfillment disruption.

Shipments

There are currently no widespread shipment delays with the exception of regions of China and Italy. We will continue to monitor FedEx service alerts and update this statement if further alerts are issued.

Staff and Travel

All business travel has been cancelled through April 15th, 2020. In the event that our facility is temporarily closed, ActiGraph personnel will work remotely to ensure that client and business needs are met. This will help ensure that site activations and patient enrollments can continue as scheduled for our pharmaceutical clients.

As the situation evolves in the coming weeks, we will continue to monitor World Health Organization and Centers for Disease Control recommendations and update our procedures accordingly.